| Targets for FY2030 | Major activities of FY2024 | Self- evalution |
|---|---|---|
| Develop and disseminate new treatments based on regenerative medicine and cell therapy |
|
〇 |
| Targets for FY2030 | Major activities of FY2024 | Self- evalution |
|---|---|---|
|
(1) Reducing burden on medical professionals by utilizing IT |
|
〇 |
| (2) Development and dissemination of infectious disease diagnostic system to contribute to global health | ||
| (3) Offering technical diagnosis training and spreading effective health practices to emerging countries | ||
| (4) Improve medical accessibility by introducing our AI-driven products/services to all 196 countries throughout the world |
- *1 It maintains the superconducting state without using any liquid helium.
| Targets for FY2030 | Major activities of FY2024 | Self- evalution |
|---|---|---|
|
|
〇 |
| Targets for FY2030 | Major activities of FY2024 | Self- evalution |
|---|---|---|
| (1) Promote to prolong healthy lives |
|
〇 |
| (2) Promote support for women’s empowerment |
- *2 Protects against ultraviolet rays, including the longest-wave ultraviolet (370–400 nm wavelength range), on the stratum corneum.
| Targets for FY2030 | Major activities of FY2024 | Self- evalution |
|---|---|---|
| Promote management of health and productivity to maintain employees’ vitality |
|
〇 |
We will continue to make capital investments in our bio-CDMO and life science businesses and provide one-stop value as a company that supports the creation of cutting-edge biopharmaceuticals.
In the medical systems business, we will continue to develop and provide a variety of products and services that meet the needs of the medical field and contribute to the development of medical care worldwide and the maintenance and improvement of people's health by positioning medical IT at the core of our business and linking each product group based on medical imaging, picture archiving and communication systems (PACS). We will also contribute to solving the issue of eliminating medical disparities through our unique solutions, such as NURA, a health screening service business in India, and tuberculosis screening using portable X-ray equipment.
Furthermore, in promoting health management, we will accelerate efforts to maintain and improve the health of employees throughout the Group in the five priority areas (lifestyle-related diseases, smoking, cancer, mental health, and long working hours), and to achieve our mid-term goal by FY2025, thereby contributing to the realization of a healthy society with longevity.